ESR1 and cancer: Indeed, as reported by Artene et al. [162], diet is effective for ER+/PR±/HER2- BC patients on anti-estrogenic medication, but adding at least a minimal exercise protocol improves patients’ chances of counteracting sarcopenic obesity, fatigue, and other negative cancer-related effects.